TrialEuropean urology2021

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts.

Mark C Markowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.